Literature DB >> 24838332

Evaluation of the Sebia CAPILLARYS 2 flex piercing for the measurement of HbA(1c) on venous and capillary blood samples.

Olivier Heylen1, Stefaan Van Neyghem1, Sandra Exterbille1, Charline Wehlou1, Frans Gorus1, Ilse Weets2.   

Abstract

OBJECTIVES: We evaluated the Sebia CAPILLARYS 2 Flex Piercing (Cap 2FP; Sebia, Lisses, France) for measurement of hemoglobin A1c (HbA1c) on venous and capillary blood samples.
METHODS: We analyzed whole-blood samples and control materials with the Cap 2FP and Tosoh G8 (Tosoh Corporation, Tokyo, Japan). Capillary blood samples were analyzed on the Cap 2FP on different storage conditions and were compared with venous samples.
RESULTS: Both instruments achieved total imprecision of less than 2.5% (International Federation of Clinical Chemistry units). Bias was 1 mmol/mol or less and 4 mmol/mol or less for the Cap 2FP and Tosoh G8, respectively. The Cap 2FP was not prone to common interferences. The Tosoh G8 showed significant bias only for carbamylated hemoglobin and did not completely separate hemoglobin D and hemoglobin E. On the Cap 2FP, storage of capillary blood at room temperature showed no significant bias. There was good agreement with venous blood.
CONCLUSIONS: The Cap 2FP and Tosoh G8 perform excellently for HbA1c determination. Capillary blood can be analyzed on the Cap 2FP as an acceptable alternative to venous blood and point-of-care testing. Home collection and central analysis of capillary blood could contribute to a reduction of health care costs without reducing quality of HbA1c determination. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  Analytical performance; Capillary zone electrophoresis; HPLC; Hemoglobin A1c

Mesh:

Substances:

Year:  2014        PMID: 24838332     DOI: 10.1309/AJCPRU5QC2JBANSV

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Assessing agreement between the three common clinical measurement methods of HbA1c.

Authors:  Mohammad Taha Jalali; Samaneh Salehipour Bavarsad; Saeed Hesam; Mohammad Reza Afsharmanesh; Narges Mohammadtaghvaei
Journal:  J Diabetes Metab Disord       Date:  2020-02-11

2.  Evaluation of hemoglobin A1c measurement by Capillarys 2 electrophoresis for detection of abnormal glucose tolerance in African immigrants to the United States.

Authors:  Zhen Zhao; Jeffrey Basilio; Steven Hanson; Randie R Little; Anne E Sumner; David B Sacks
Journal:  Clin Chim Acta       Date:  2015-04-08       Impact factor: 3.786

3.  Evaluation of a new hemoglobin A1c analyzer for point-of-care testing.

Authors:  Rui Zhou; Wei Wang; Zhi-Xin Song; Qing Tong; Qing-Tao Wang
Journal:  J Clin Lab Anal       Date:  2017-02-21       Impact factor: 2.352

4.  A comparative evaluation of the analytical performances of Capillarys 2 Flex Piercing, Tosoh HLC-723 G8, Premier Hb9210, and Roche Cobas c501 Tina-quant Gen 2 analyzers for HbA1c determination.

Authors:  Xiaobin Wu; Yan Chao; Zemin Wan; Yunxiu Wang; Yan Ma; Peifeng Ke; Xinzhong Wu; Jianhua Xu; Junhua Zhuang; Xianzhang Huang
Journal:  Biochem Med (Zagreb)       Date:  2016-10-15       Impact factor: 2.313

5.  Verification of a novel point-of-care HbA1c device in real world clinical practice by comparison to three high performance liquid chromatography instruments.

Authors:  Yufei Wang; Wei Peng; Junling Tang; Lu Dong; Chengchen Gu; Xin Zhang; Jian Zhou; Weiping Jia
Journal:  Biochem Med (Zagreb)       Date:  2018-04-15       Impact factor: 2.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.